Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
MooGoo Skin Milk Udder cream
131500000BBNFA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 118 |
|
MooGoo Sensitive skin balm
131500000BBNDA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 85 |
|
MooGoo Scalp cream
131500000BBNEA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 54 |
|
Lipikar Baume AP+ Lipid-Replenishing balm
131500000BBNCA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 31 |
|
Monobenzone 20% in Aqueous cream
131500000AABSBS
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 3 |
|
Monobenzone 40% in Cetomacrogol cream (Formula A)
131500000AABXBX
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 2 |
|
Monobenzone 10% in Aqueous cream
131500000AABTBT
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 1 |
|
Emerita Pro-Gest cream
131500000BBNBA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Glycerin of Starch BPC 1963
131500000AABNBN
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 10% in Cetomacrogol cream (Formula A)
131500000AABUBU
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 10% in Generic Unguentum M cream
131500000AABPBP
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 20% in Cetomacrogol cream (Formula A)
131500000AABVBV
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 20% in Generic Unguentum M cream
131500000AABYBY
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 30% in Aqueous cream
131500000AABQBQ
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 30% in Cetomacrogol cream (Formula A)
131500000AABWBW
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Monobenzone 40% in Aqueous cream
131500000AABRBR
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Pro-Juven 1.5% cream
131500000BBMTA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Pro-Juven 3% cream
131500000BBMSA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Tri-Luma cream
131500000BBNAA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Udderly Smooth Extra Care cream with 10% urea
131500000BBNIA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Udderly Smooth moisturising cream
131500000BBNHA0
|
Proprietary compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
|
Zinc oxide 15% / Ichthammol 1% ointment
131500000AABCBC
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.